Tag: Therapeutics

This text was written byComply withTerry Chrisomalis is a non-public investor within the Biotech sector with years of expertise using ...

This text was written byObserveIn search of Alpha's transcripts group is chargeable for the event of all of our transcript-related ...

Fulcrum Therapeutics, Inc. (NASDAQ:FULC) This fall 2024 Earnings Convention Name February 25, 2025 8:00 AM ET Firm Individuals Alex Sapir ...

Stuart Therapeutics provides acknowledged leaders in ophthalmology therapeutics growth, commercialization. STUART, Fla., Dec. 22, 2024 /PRNewswire/ --  Stuart Therapeutics introduced ...

Depth Therapeutics, Inc. (NASDAQ: INTS) is a scientific biotechnology firm engaged within the discovery growth, and commercialization of first-in-class most ...

On Friday, Piper Sandler confirmed its Obese ranking on Tenaya Therapeutics Inc (NASDAQ:TNYA) with a gentle worth goal of $40.00. ...

Eliem Therapeutics, Inc.'s (NASDAQ:ELYM) Chief Accounting Officer, Emily Pimblett, has just lately offered a portion of her firm inventory, in ...

Biora Therapeutics, Inc. (NASDAQ:BIOR) Q2 2024 Earnings Convention Name August 12, 2024 4:30 PM ET Firm Individuals Chuck Padala - ...

Michael Vi/iStock Editorial by way of Getty Photos AbbVie (NYSE:ABBV) has accomplished its ~$8.7B ($45 per share) acquisition of Cerevel ...

JOSE LUIS CALVO MARTIN & JOSE ENRIQUE GARCIA-MAURIÑO MUZQUIZ Sarepta Therapeutics, Inc. (NASDAQ:SRPT) is synonymous with Duchenne Muscular Dystrophy ("DMD"). ...